About Jike Biotech

We integrate research and development, production, and strategic marketing, specializing in OEM and ODM services with one-stop skincare solutions across all categories.

WHO WE ARE

Jike Biotech (Guangzhou) Co., Ltd. operates at the intersection of biopharmaceutical science and cosmetic manufacturing. Our core product lines include repair, anti-aging, brightening, lyophilized powder, ampoule serums, and herbal Chinese medicine skincare series. With craftsmanship quality and innovation driving the future, we partner with brands worldwide to bring high-purity peptide solutions to market.

From early-stage formulation to full-scale production, our teams are structured to support both emerging labels and established distributors with reliable, compliant, and scalable OEM / ODM programs.

Jike Biotech production facility corridor

DEVELOPMENT PATH

A trajectory defined by scientific rigor, manufacturing scale, and continuous innovation.

2013

The company is established as a global strategic affiliate of an Active Peptide Company in the United States; a biomedical R&D platform is set up with Jining High-tech Zone.

2014

The main product copper peptide is successfully developed; the famous American biochemist and inventor of copper peptide, Dr. Loren Pickart, becomes a customer and endorses the product; a global customer service center is established in Boston, USA, and the product enters the global market.

2015

Snake venom tripeptide process is successfully researched; Dr. Yu wins the honorary title of “Shandong Taishan Scholar”; the company begins to participate in global exhibitions.

2016

Acetyl dipeptide cetyl ester, Pal-GHK and dipeptide-2 are successfully developed; the famous American skin care brand Osmotics begins to use our products in large quantities; liquid peptide products are launched.

2017

New technology of Biotin-GHK, Hexapeptide-11 and Pal-GQPR is successfully developed; the R&D base passes the factory audit of Hyundai IBT, the largest cosmeceutical company in South Korea.

2018

Acetyl Hexapeptide-8 is successfully developed; cooperation begins with well-known domestic agents; KDC, a famous Canadian brand, uses our products.

2019

The GMP workshop of the Life Science Center is put into use; beauty peptide products enter Bloomage Bio, Winona and Plant Doctor.

2020

The liquid-phase synthesis technology of three products including biotin tripeptide-1 obtains the national invention patent; Trans-4-tert-butylcyclohexanol and ceramide are successfully developed.

2021

The factory in the chemical park that meets provincial standards is under construction; the company enters its first round of financing; new product development and patent applications progress.

2022

The copper peptide patent is granted; the high-precision new medical park is put into use.

2023

The high-precision new medical park is fully in use, expanding large-scale peptide production capacity.